| scholarly article | Q13442814 |
| P2093 | author name string | Shantel Olivares | |
| Anne S Henkel | |||
| P2860 | cites work | A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response | Q24305069 |
| FGF-21 as a novel metabolic regulator | Q24523933 | ||
| Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State | Q24625976 | ||
| Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo | Q24632545 | ||
| FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response | Q24653481 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes | Q28571616 | ||
| FGF21 is an endocrine signal of protein restriction | Q28572009 | ||
| Fibroblast growth factor 21 is induced by endoplasmic reticulum stress | Q28581415 | ||
| Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 | ||
| Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 | ||
| FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans | Q29655262 | ||
| Homocysteine supplementation attenuates the unfolded protein response in a murine nutritional model of steatohepatitis | Q33553744 | ||
| ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress | Q33681667 | ||
| Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding. | Q34299026 | ||
| Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis | Q34396839 | ||
| A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice | Q34503382 | ||
| Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus | Q34699946 | ||
| Fibroblast growth factor 21 corrects obesity in mice | Q34805555 | ||
| p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis | Q35419603 | ||
| Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet | Q35613153 | ||
| Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice | Q35709954 | ||
| Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets | Q36061647 | ||
| Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. | Q36330343 | ||
| Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet | Q36382065 | ||
| Hepatic Xbp1 Gene Deletion Promotes Endoplasmic Reticulum Stress-induced Liver Injury and Apoptosis | Q36444262 | ||
| The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism | Q36497151 | ||
| IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis | Q36600595 | ||
| Fibroblast growth factor 21 mediates specific glucagon actions | Q36796145 | ||
| Adaptive changes in amino acid metabolism permit normal longevity in mice consuming a low-carbohydrate ketogenic diet | Q36889022 | ||
| Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease | Q36889026 | ||
| Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity | Q37328872 | ||
| Interplay between FGF21 and insulin action in the liver regulates metabolism | Q37524205 | ||
| A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | Q37571422 | ||
| PPARalpha is a key regulator of hepatic FGF21. | Q38300403 | ||
| Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. | Q41760918 | ||
| Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. | Q42972684 | ||
| Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
| Response to carbohydrate and fat refeeding in the expression of genes involved in nutrient partitioning and metabolism: striking effects on fibroblast growth factor-21 induction. | Q43259536 | ||
| Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. | Q45966977 | ||
| Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. | Q46327498 | ||
| The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. | Q46445480 | ||
| Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans | Q46770146 | ||
| FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting | Q48659709 | ||
| Hepatic IRE1α regulates fasting-induced metabolic adaptive programs through the XBP1s-PPARα axis signalling. | Q51324999 | ||
| Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. | Q51379603 | ||
| Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. | Q53654532 | ||
| A high-fat, ketogenic diet induces a unique metabolic state in mice | Q79771171 | ||
| Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21 | Q84079985 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 1616-1624 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | Molecular Metabolism | Q27724805 |
| P1476 | title | Induction of fibroblast growth factor 21 does not require activation of the hepatic X-box binding protein 1 in mice | |
| P478 | volume | 6 |
Search more.